Ubiquitome
Auckland, New Zealand· Est.
Portable, low‑cost qPCR devices that bring rapid, lab‑grade diagnostics to any field.
Is this your company? Claim your profile to update info and connect with investors.
Claim profilePrivate Company
Estimated funding: $5M
AI Company Overview
Portable, low‑cost qPCR devices that bring rapid, lab‑grade diagnostics to any field.
Infectious DiseasesVeterinary DiagnosticsAgricultural Diagnostics
Technology Platform
Handheld real‑time PCR (qPCR) with Bluetooth‑enabled iPhone app for cloud‑connected data acquisition and automated analysis.
Opportunities
Expansion into emerging markets for point‑of‑care molecular diagnostics and development of disease assay panels for human, veterinary, and agricultural sectors.
Risk Factors
Regulatory hurdles across jurisdictions, intense competition from established portable PCR manufacturers, and reliance on supply‑chain stability for low‑cost components.
Competitive Landscape
Competes with Biomeme, Cepheid, and Thermo Fisher’s portable PCR solutions; differentiates via a truly handheld form factor, lower price, and cloud‑first data workflow.